Historical record - last NADAC effective date: 7/17/2024

Product Information

MOMETASONE FUROATE 0.1% SOLN is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3793 per ML under NDC 68462038537. Its NADAC has been published 322 times since Nov 28, 2013.

FDA first approved this application on Aug 9, 2010.

MOMETASONE FUROATE 0.1% SOLN

Mometasone Furoate
$0.3793per ML

Strength

1 mg/mL

NDC

68462038537

Classification

Generic

Dosage Form

LOTION

Route

TOPICAL

Effective Date

7/17/2024

Active Ingredients

MOMETASONE FUROATE

Approval Type

Generic (ANDA)

FDA Application

ANDA090506

FDA Approved

8/9/2010

On Market Since

6/1/2020

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for MOMETASONE FUROATE 0.1% SOLN has been published 322 times since Nov 28, 2013, and over the history we have for it it has risen 7.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3793 per ML
All-time high$0.4718 (Apr 10, 2024)
All-time low$0.2257 (Sep 21, 2016)
Median price$0.3493
Average price$0.3374
Largest weekly change+52.9% (Jun 2, 2021)
Weeks tracked322
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-12.0%

5Y

+7.7%

All

+7.0%

Last surveyed Jul 31, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of MOMETASONE FUROATE 0.1% SOLN?

The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 0.1% SOLN, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3793 per ML (NDC 68462038537), effective Jul 31, 2024.

How has the price of MOMETASONE FUROATE 0.1% SOLN changed over time?

Over the history we have for it, the NADAC for MOMETASONE FUROATE 0.1% SOLN has risen 7.0%. It has been tracked across 322 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 0.1% SOLN?

Since Nov 28, 2013, the NADAC for MOMETASONE FUROATE 0.1% SOLN has ranged from a low of $0.2257 (Sep 21, 2016) to a high of $0.4718 (Apr 10, 2024), with a median of $0.3493 per ML.

Are there cheaper alternatives to MOMETASONE FUROATE 0.1% SOLN?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MOMETASONE FUROATE 0.1% SOLN, is $0.3759 per ML — about 1% below MOMETASONE FUROATE 0.1% SOLN.

Who manufactures MOMETASONE FUROATE 0.1% SOLN?

MOMETASONE FUROATE 0.1% SOLN (NDC 68462038537) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.